COMPARISON OF BUTORPHANOL VERSUS MORPHINE AS AN ADDITION TO EPIDURAL ROPIVACAINE FOR POSTOPERATIVE PAIN RELIEF IN UTERUS RELATED SURGERIES
Not Applicable
- Conditions
- Health Condition 1: 1- Obstetrics
- Registration Number
- CTRI/2021/12/038609
- Lead Sponsor
- SUDHAS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)PATIENTS UNDERGOING ELECTIVE TOTAL ABDOMINAL HYSTERECTOMY SURGERIES.
2)ASA1 AND ASA2
Exclusion Criteria
1)PATIENT NOT WILLING
2)PATIENT HAVING DRUG ALLERGIES TO SPECIFIC DRUG
3)PATIENTS WITH ANY CONTRAINDICATIONS FOR EPIDURAL ANAESTHESIA
4)PATIENTS WITH INTRAOPERATIVE SURGICAL COMPLICATIONS LIKE MASSIVE BLOOD LOSS AND HEMODYNAMIC INSTABILITY
5)PATIENTS WITH SENSORY AND MOTOR DEFICIT
6)ASA3 AND ASA4
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DURATION AND QUALITY OF POSTOPERATIVE ANALGESIATimepoint: 24HRS
- Secondary Outcome Measures
Name Time Method 1)NUMBER OF RESCUE ANALGESIA INBETWEEN <br/ ><br>2)HAEMODYNAMIC CHANGESTimepoint: 24HRS